Figure 9.Validation of the five-gene based on the SVM model. (A) Development of a nomogram utilising the 5-gene based on the SVM model to predict the risk of AD patients. (B) Assessment of the prognostic efficacy of the nomogram model through a calibration curve. (C) Utilisation of discriminant analysis for evaluating the sensitivity of the nomogram to change.
